ALZCHEM GROUP AG (ACT.DE) Forecast, Price Target & Analyst Ratings

FRA:ACT • DE000A2YNT30

Current stock price

169.4 EUR
+6 (+3.67%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALZCHEM GROUP AG (ACT.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€180.48
+ 6.54% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 30, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.27%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€180.48
Upside
+ 6.54%
From current price of €169.40 to mean target of €180.48, Based on 11 analyst forecasts
Low
€166.65
Median
€178.50
High
€196.04

Price Target Revisions

1 Month
0.00%
3 Months
13.82%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for ACT.DE. The average price target is 180.48 EUR. This implies a price increase of 6.54% is expected in the next year compared to the current price of 169.4.
The average price target has been revised upward by 13.82% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ACT Current Analyst RatingACT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ACT Historical Analyst RatingsACT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
87.27%
ACT.DE was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ACT.DE.
In the previous month the buy percentage consensus was at a similar level.
ACT.DE was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-02BerenbergMaintains Buy -> Buy
2025-12-11BerenbergMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 30, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ACT.DE revenue by date.ACT.DE revenue by date.
540.649M
-0.29%		554.231M
2.51%		562.115M
1.42%		622.88M
10.81%		727.99M
16.87%		829.15M
13.90%		901.74M
8.75%		977M
8.35%		1.028B
5.22%		1.081B
5.16%		1.133B
4.81%
EBITDA
YoY % growth
ACT.DE ebitda by date.ACT.DE ebitda by date.
83.016M
35.34%		106.438M
28.21%		119.738M
12.50%		130.22M
8.75%		163.69M
25.70%		210.69M
28.71%		222.65M
5.68%		245.12M
10.09%		269.63M
10.00%		288.02M
6.82%		308.45M
7.09%
EBIT
YoY % growth
ACT.DE ebit by date.ACT.DE ebit by date.
57.116M
59.56%		80.12M
40.28%		93.09M
16.19%		95.203M
2.27%		122.63M
28.81%		141.18M
15.13%		172.44M
22.14%		191.4M
11.00%		207.48M
8.40%		221.17M
6.60%		236.08M
6.74%
Operating Margin
ACT.DE operating margin by date.ACT.DE operating margin by date.
10.56%14.46%16.56%15.28%16.85%17.03%19.12%19.59%20.18%20.46%20.84%
EPS
YoY % growth
ACT.DE eps by date.ACT.DE eps by date.
N/A
43.17%		N/A
43.58%		N/A
20.69%		6.49
5.53%		8.27
27.48%		12.39
49.85%		N/AN/AN/AN/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.32%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
12.68%
Revenue Next 5 Year
11.01%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
32.94%
EBIT Next 5 Year
22.28%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ALZCHEM GROUP AG / ACT.DE Forecast FAQ

What do analysts expect the price target to be for ALZCHEM GROUP AG (ACT.DE)?

11 analysts have analysed ACT.DE and the average price target is 180.48 EUR. This implies a price increase of 6.54% is expected in the next year compared to the current price of 169.4.

What is the next earnings date for ACT stock?

ALZCHEM GROUP AG (ACT.DE) will report earnings on 2026-04-30.

What is the consensus rating for ACT stock?

The consensus rating for ALZCHEM GROUP AG (ACT.DE) is 87.2727 / 100 . This indicates that analysts generally have a positive outlook on the stock.